1. Holmes G. The cerebellum of man. Brain. 1939;62:1–31.

2. Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke’s Encephalopathy and Korsakoff’s Psychosis. Alcohol Alcohol. 2006;41:151–8.

3. O’Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med. 1998;338:592–602.

4. Brust JC. Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. Int J Environ Res Public Health. 2010;7:1540–57.

5. Deshmukh A, Rosenbloom MJ, Pfefferbaum A, Sullivan EV. Clinical signs of cerebellar dysfunction in schizophrenia, alcoholism, and their comorbidity. Schizophr Res. 2002;57:281–91.

6. Sullivan EV, Desmond JE, Lim KO, Pfefferbaum A. Speed and efficiency but not accuracy or timing deficits of limb movements in alcoholic men and women. Alcohol Clin Exp Res. 2002;26:705–13.

7. Sullivan EV, Rosenbloom MJ, Lim KO, Pfefferbaum A. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure. Neuropsychology. 2000;14:178–88.

8. Woodruff-Pak DS, Papka M, Romano S, Li YT. Eyeblink classical conditioning in Alzheimer’s disease and cerebrovascular dementia. Neurobiol Aging. 1996;17:505–12.

9. York JL, Biederman I. Hand movement speed and accuracy in detoxified alcoholics. Alcohol Clin Exp Res. 1991;15:982–90.

10. Dohrman DP, West JR, Pantazis NJ. Ethanol reduces expression of the nerve growth factor receptor, but not nerve growth factor protein levels in the neonatal rat cerebellum. Alcohol Clin Exp Res. 1997;21:882–93.

11. Schlerf J, Wiestler T, Verstynen T, Diedrichsen J. Big challenges from the little brain—imaging the cerebellum. In: Papageorgiou TD, Christopoulos GI, Smirnakis SM, editors. Advanced brain neuroimaging topics in health and disease—methods and applications. 2014.

12. Bauer-Moffett C, Altman J. The effect of ethanol chronically administered to preweaning rats on cerebellar development: a morphological study. Brain Res. 1977;119:249–68.

13. Dlugos CA. Ethanol-related increases in degenerating bodies in the Purkinje neuron dendrites of aging rats. Brain Res. 2008;1221:98–107.

14. Zahr NM, Bell RL, Ringham HN, Sullivan EV, Witzmann FA, Pfefferbaum A. Ethanol-induced changes in the expression of proteins related to neurotransmission and metabolism in different regions of the rat brain. Pharmacol Biochem Behav;99:428-36.

15. Li CY, Chin TY, Chueh SH. Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity by S-nitrosoglutathione but not glutathione. Am J Physiol Cell Physiol. 2004;286:C893–904.

16. Prendergast MA, Harris BR, Mullholland PJ, Blanchard 2nd JA, Gibson DA, Holley RC, et al. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-D-aspartate receptors. Neuroscience. 2004;124:869–77.

17. Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry. 1998;155:726–32.

18. Finn DA, Crabbe JC. Exploring alcohol withdrawal syndrome. Alcohol Health Res World. 1997;21:149–56.

19. Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79:1431–568.

20. Sandoval ME, Cotman CW. Evaluation of glutamate as a neurotransmitter of cerebellar parallel fibers. Neuroscience. 1978;3:199–206.

21. Gallo V, Ciotti MT, Coletti A, Aloisi F, Levi G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci U S A. 1982;79:7919–23.

22. Ganakas AM, Mercer LD, Shinozaki H, Beart PM. Characteristics and localization of high-affinity kainate sites in slide-mounted sections of rat cerebellum. Neurosci Lett. 1994;178:124–6.

23. Petralia RS, Wang YX, Wenthold RJ. Histological and ultrastructural localization of the kainate receptor subunits, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies. J Comp Neurol. 1994;349:85–110.

24. Rossi F, Borsello T, Strata P. Exposure to kainic acid mimics the effects of axotomy in cerebellar Purkinje cells of the adult rat. Eur J Neurosci. 1994;6:392–402.

25. Netzeband JG, Schneeloch JR, Trotter C, Caguioa-Aquino JN, Gruol DL. Chronic ethanol treatment and withdrawal alter ACPD-evoked calcium signals in developing Purkinje neurons. Alcohol Clin Exp Res. 2002;26:386–93.

26. Virmani M, Majchrowicz E, Swenberg CE, Gangola P, Pant HC. Alteration in calcium-binding activity in synaptosomal membranes from rat brains in association with physical dependence upon ethanol. Brain Res. 1985;359:371–4.

27. Follesa P, Mancuso L, Biggio F, Mostallino MC, Manca A, Mascia MP, et al. Gamma-hydroxybutyric acid and diazepam antagonize a rapid increase in GABA(A) receptors alpha(4) subunit mRNA abundance induced by ethanol withdrawal in cerebellar granule cells. Mol Pharmacol. 2003;63:896–907.

28. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke. 1998;29:705–18.

29. Jung ME, Ju X, Simpkins JW, Metzger DB, Yan LJ, Wen Y. Ethanol withdrawal acts as an age-specific stressor to activate cerebellar p38 kinase. Neurobiol Aging. 2011;32:2266–78.

30. Salvi J, Bertaso F, Mausset-Bonnefont AL, Metz A, Lemmers C, Ango F, et al. RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2. Neurobiol Dis. 2014;68:47–56.

31. N’Gouemo P, Morad M. Ethanol withdrawal seizure susceptibility is associated with upregulation of L- and P-type Ca2+ channel currents in rat inferior colliculus neurons. Neuropharmacology. 2003;45:429–37.

32. Caillard O, Moreno H, Schwaller B, Llano I, Celio MR, Marty A. Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad Sci U S A. 2000;97:13372–7.

33. Vecellio M, Schwaller B, Meyer M, Hunziker W, Celio MR. Alterations in Purkinje cell spines of calbindin D-28 k and parvalbumin knock-out mice. Eur J Neurosci. 2000;12:945–54.

34. Ince P, Stout N, Shaw P, Slade J, Hunziker W, Heizmann CW, et al. Parvalbumin and calbindin D-28 k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol. 1993;19:291–9.

35. Sloviter RS. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol. 1989;280:183–96.

36. Rewal M, Wen Y, Wilson A, Simpkins JW, Jung ME. Role of parvalbumin in estrogen protection from ethanol withdrawal syndrome. Alcohol Clin Exp Res. 2005;29:1837–44.

37. Bassani JW, Bassani RA, Bers DM. Ca2+ cycling between sarcoplasmic reticulum and mitochondria in rabbit cardiac myocytes. J Physiol. 1993;460:603–21.

38. Csordas G, Thomas AP, Hajnoczky G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J. 1999;18:96–108.

39. Duchen MR, Leyssens A, Crompton M. Transient mitochondrial depolarizations reflect focal sarcoplasmic reticular calcium release in single rat cardiomyocytes. J Cell Biol. 1998;142:975–88.

40. Hajnoczky G, Csordas G, Yi M. Old players in a new role: mitochondria-associated membranes, VDAC, and ryanodine receptors as contributors to calcium signal propagation from endoplasmic reticulum to the mitochondria. Cell Calcium. 2002;32:363–77.

41. Rizzuto R, Brini M, Murgia M, Pozzan T. Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science. 1993;262:744–7.

42. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 1998;280:1763–6.

43. Simpson PB, Russell JT. Mitochondria support inositol 1,4,5-trisphosphate-mediated Ca2+ waves in cultured oligodendrocytes. J Biol Chem. 1996;271:33493–501.

44. McCormack JG, Denton RM. Mitochondrial Ca2+ transport and the role of intramitochondrial Ca2+ in the regulation of energy metabolism. Dev Neurosci. 1993;15:165–73.

45. Chen G, Racay P, Bichet S, Celio MR, Eggli P, Schwaller B. Deficiency in parvalbumin, but not in calbindin D-28 k upregulates mitochondrial volume and decreases smooth endoplasmic reticulum surface selectively in a peripheral, subplasmalemmal region in the soma of Purkinje cells. Neuroscience. 2006;142:97–105.

46. Hartmann J, Konnerth A. Determinants of postsynaptic Ca2+ signaling in Purkinje neurons. Cell Calcium. 2005;37:459–66.

47. Shoshan-Barmatz V, Zalk R, Gincel D, Vardi N. Subcellular localization of VDAC in mitochondria and ER in the cerebellum. Biochim Biophys Acta. 2004;1657:105–14.

48. Jung ME, Wilson AM, Ju X, Wen Y, Metzger DB, Simpkins JW. Ethanol withdrawal provokes opening of the mitochondrial membrane permeability transition pore in an estrogen-preventable manner. J Pharmacol Exp Ther. 2009;328:692–8.

49. Berman SB, Watkins SC, Hastings TG. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria. Exp Neurol. 2000;164:415–25.

50. Chinopoulos C, Starkov AA, Fiskum G. Cyclosporin A-insensitive permeability transition in brain mitochondria: inhibition by 2-aminoethoxydiphenyl borate. J Biol Chem. 2003;278:27382–9.

51. Mori N, Yasutake A, Marumoto M, Hirayama K. Methylmercury inhibits electron transport chain activity and induces cytochrome c release in cerebellum mitochondria. J Toxicol Sci. 2011;36:253–9.

52. Mori N, Yasutake A, Hirayama K. Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch Toxicol. 2007;81:769–76.

53. Matyja E, Albrecht J. Ultrastructural evidence that mercuric chloride lowers the threshold for glutamate neurotoxicity in an organotypic culture of rat cerebellum. Neurosci Lett. 1993;158:155–8.

54. Holtzman D, Hsu JS. Early effects of inorganic lead on immature rat brain mitochondrial respiration. Pediatr Res. 1976;10:70–5.

55. Jung ME, Yan LJ, Forster MJ, Simpkins JW. Ethanol withdrawal provokes mitochondrial injury in an estrogen7 preventable manner. J Bioenerg Biomembr. 2008;40:35–44.

56. Siler-Marsiglio KI, Pan Q, Paiva M, Madorsky I, Khurana NC, Heaton MB. Mitochondrially targeted vitamin E and vitamin E mitigate ethanol-mediated effects on cerebellar granule cell antioxidant defense systems. Brain Res. 2005;1052:202–11.

57. Cantoni GL. Activation of methionine for transmethylation. J Biol Chem. 1951;189:745–54.

58. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997;73:265–80.

59. Bailey SM, Robinson G, Pinner A, Chamlee L, Ulasova E, Pompilius M, et al. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am J Physiol Gastrointest Liver Physiol. 2006;291:G857–67.

60. Kobayashi K, Nakajima E, Kubo Y, Yasukawa Y, Iwata N. S-adenosyl-L-methionine ameliorates reduced local cerebral glucose utilization following brain ischemia in the rat. Jpn J Pharmacol. 1990;52:141–8.

61. Kennedy BE, LeBlanc VG, Mailman TM, Fice D, Burton I, Karakach TK, et al. Pre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick Type C1-deficient murine brain. PLoS One. 2013;8:e82685.

62. Batlevi Y, La Spada AR. Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging. Neurobiol Dis. 2010;43:46–51.

63. Shephard F, Greville-Heygate O, Marsh O, Anderson S, Chakrabarti L. A mitochondrial location for haemoglobins—dynamic distribution in ageing and Parkinson’s disease. Mitochondrion. 2014;14:64–72.

64. Gizatullina ZZ, Gaynutdinov TM, Svoboda H, Jerzembek D, Knabe A, Vielhaber S, et al. Effects of cyclosporine A and its immunosuppressive or non-immunosuppressive derivatives [D-Ser]8-CsA and Cs9 on mitochondria from different brain regions. Mitochondrion. 2011;11:421–9.

65. Brown MR, Geddes JW, Sullivan PG. Brain region-specific, age-related, alterations in mitochondrial responses to elevated calcium. J Bioenerg Biomembr. 2004;36:401–6.

66. Venkateshappa C, Harish G, Mahadevan A, Srinivas Bharath MM, Shankar SK. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer’s disease. Neurochem Res. 2012;37:1601–14.

67. Baek BS, Kwon HJ, Lee KH, Yoo MA, Kim KW, Ikeno Y, et al. Regional difference of ROS generation, lipid peroxidation, and antioxidant enzyme activity in rat brain and their dietary modulation. Arch Pharm Res. 1999;22:361–6.

68. Ram Kumar M, Flora SJ, Reddy GR. Monoisoamyl 2,3-dimercaptosuccinic acid attenuates arsenic induced toxicity: behavioral and neurochemical approach. Environ Toxicol Pharmacol. 2013;36:231–42.

69. Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P. Alpha-synuclein and Parkinson’s disease. FASEB J. 2004;18:617–26.

70. Liu G, Zhang C, Yin J, Li X, Cheng F, Li Y, et al. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett. 2009;454:187–92.

71. Fan L, van der Brug M, Chen W, Dodd PR, Matsumoto I, Niwa S, et al. Increased expression of mitochondrial genes in human alcoholic brain revealed by differential display. Alcohol Clin Exp Res. 1999;23:408–13.

72. Morio Y, Tsuji M, Inagaki M, Nakagawa M, Asaka Y, Oyamada H, et al. Ethanol-induced apoptosis in human liver adenocarcinoma cells (SK-Hep1): Fas- and mitochondria-mediated pathways and interaction with MAPK signaling system. Toxicol In Vitro. 2013;27:1820–9.

73. Oudea MC, Collette M, Oudea P. Morphometric study of ultrastructural changes induced in rat liver by chronic alcohol intake. Am J Dig Dis. 1973;18:398–402.

74. Cahill A, Hershman S, Davies A, Sykora P. Ethanol feeding enhances age-related deterioration of the rat hepatic mitochondrion. Am J Physiol Gastrointest Liver Physiol. 2005;289:G1115–23.

75. de La Monte SM, Wands JR. Mitochondrial DNA damage and impaired mitochondrial function contribute to apoptosis of insulin-stimulated ethanol-exposed neuronal cells. Alcohol Clin Exp Res. 2001;25:898–906.

76. Mansouri A, Demeilliers C, Amsellem S, Pessayre D, Fromenty B. Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther. 2001;298:737–43.

77. Lieber CS. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998)—a review. Alcohol Clin Exp Res. 1999;23:991–1007.

78. Bailey SM, Pietsch EC, Cunningham CC. Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radic Biol Med. 1999;27:891–900.

79. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic Biol Med. 2002;32:110–4.

80. Bailey SM. A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Radic Res. 2003;37:585–96.

81. Klein H, Harmjanz D. Effect of ethanol infusion on the ultrastructure of human myocardium. Postgrad Med J. 1975;51:325–9.

82. Regan TJ. Alcohol and the cardiovascular system. JAMA. 1990;264:377–81.

83. Pachinger O, Mao J, Fauvel JM, Bing RJ. Mitochondrial function and excitation-contraction coupling in the development of alcoholic cardiomyopathy. Recent Adv Stud Card Struct Metab. 1975;5:423–9.

84. Jaatinen P, Riikonen J, Riihioja P, Kajander O, Hervonen A. Interaction of aging and intermittent ethanol exposure on brain cytochrome c oxidase activity levels. Alcohol. 2003;29:91–100.

85. Ramachandran V, Perez A, Chen J, Senthil D, Schenker S, Henderson GI. In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4-hydroxynonenal. Alcohol Clin Exp Res. 2001;25:862–71.

86. Rouach H, Clement M, Orfanelli MT, Janvier B, Nordmann J, Nordmann R. Hepatic lipid peroxidation and mitochondrial susceptibility to peroxidative attacks during ethanol inhalation and withdrawal. Biochim Biophys Acta. 1983;753:439–44.

87. Olguin-Martinez M, Hernandez-Espinosa DR, Hernandez-Munoz R. alpha-Tocopherol administration blocks adaptive changes in cell NADH/NAD + redox state and mitochondrial function leading to inhibition of gastric mucosa cell proliferation in rats. Free Radic Biol Med. 2013;65:1090–100.

88. Chen W, Hardy P, Wilce PA. Differential expression of mitochondrial NADH dehydrogenase in ethanol-treated rat brain: revealed by differential display. Alcohol Clin Exp Res. 1997;21:1053–6.

89. Iorio KR, Reinlib L, Tabakoff B, Hoffman PL. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. Mol Pharmacol. 1992;41:1142–8.

90. Dietrich WD, Halley M, Alonso O, Globus MY, Busto R. Intraventricular infusion of N-methyl-D-aspartate. 2. Acute neuronal consequences. Acta Neuropathol. 1992;84:630–7.

91. Reddy NR, Krishnamurthy S, Chourasia TK, Kumar A, Joy KP. Glutamate antagonism fails to reverse mitochondrial dysfunction in late phase of experimental neonatal asphyxia in rats. Neurochem Int. 2011;58:582–90.

92. Tavares MA, Paula-Barbosa MM. Mitochondrial changes in rat Purkinje cells after prolonged alcohol consumption. A morphologic assessment. J Submicrosc Cytol. 1983;15:713–20.

93. Detmer SA, Chan DC. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J Cell Biol. 2007;176:405–14.

94. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–52.

95. Chen H, Chan DC. Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol. 2006;18:453–9.

96. Chen H, McCaffery JM, Chan DC. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell. 2007;130:548–62.

97. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005;280:26185–92.

98. Koch OR, Pani G, Borrello S, Colavitti R, Cravero A, Farre S, et al. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med. 2004;25:191–8.

99. Koch OR, de Conti LL R, Bolanos LP, Stoppani AO. Ultrastructural and biochemical aspects of liver mitochondria during recovery from ethanol-induced alterations. Experimental evidence of mitochondrial division. Am J Pathol. 1978;90:325–44.

100. Tabouy L, Zamora AJ, Oliva L, Montet AM, Beauge F, Montet JC. Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury. Life Sci. 1998;63:2259–70.

101. Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, et al. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis. 2011;2:e240.

102. Kumari S, Mehta SL, Li PA. Glutamate induces mitochondrial dynamic imbalance and autophagy activation: preventive effects of selenium. PLoS One. 2012;7:e39382.

103. Grohm J, Plesnila N, Culmsee C. Bid mediates fission, membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death. Brain Behav Immun. 2010;24:831–8.

104. Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology. 2002;122:2049–63.

105. Slater TF. Free-radical mechanisms in tissue injury. Biochem J. 1984;222:1–15.

106. Zimatkin SM, Deitrich RA. Aldehyde dehydrogenase activities in the brains of rats and mice genetically selected for different sensitivity to alcohol. Alcohol Clin Exp Res. 1995;19:1300–6.

107. Behrens UJ, Hoerner M, Lasker JM, Lieber CS. Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo. Biochem Biophys Res Commun. 1988;154:584–90.

108. Upadhya SC, Ravindranath V. Detection and localization of protein-acetaldehyde adducts in rat brain after chronic ethanol treatment. Alcohol Clin Exp Res. 2002;26:856–63.

109. Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci. 2010;2:12.

110. Satoh T, Numakawa T, Abiru Y, Yamagata T, Ishikawa Y, Enokido Y, et al. Production of reactive oxygen species and release of L-glutamate during superoxide anion-induced cell death of cerebellar granule neurons. J Neurochem. 1998;70:316–24.

111. Wang X, Zaidi A, Pal R, Garrett AS, Braceras R, Chen XW, et al. Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress. BMC Neurosci. 2009;10:12.

112. Renovell A, Giner J, Portoles M. Loss of granule neurons in the aging human cerebellar cortex. Int J Dev Biol. 1996;Suppl 1:193S–4.

113. Andersen BB, Gundersen HJ, Pakkenberg B. Aging of the human cerebellum: a stereological study. J Comp Neurol. 2003;466:356–65.

114. Kaur P, Aschner M, Syversen T. Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology. 2007;230:164–77.

115. Scorziello A, Pellegrini C, Forte L, Tortiglione A, Gioielli A, Iossa S, et al. Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation. J Neurosci Res. 2001;63:20–6.

116. Aschner M, Syversen T, Souza DO, Rocha JB, Farina M. Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. Braz J Med Biol Res. 2007;40:285–91.

117. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat. 1996;10:179–90.

118. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996;9:836–44.

119. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30:620–50.

120. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci. 2002;5:291–309.

121. Minc-Golomb D, Yadid G, Tsarfaty I, Resau JH, Schwartz JP. In vivo expression of inducible nitric oxide synthase in cerebellar neurons. J Neurochem. 1996;66:1504–9.

122. Rhyu IJ, Nahm SS, Hwang SJ, Kim H, Suh YS, Oda SI, et al. Altered neuronal nitric oxide synthase expression in the cerebellum of calcium channel mutant mice. Brain Res. 2003;977:129–40.

123. Campese VM, Sindhu RK, Ye S, Bai Y, Vaziri ND, Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res. 2007;1134:27–32.

124. Oldreive CE, Gaynor S, Doherty GH. Effects of nitric oxide on the survival and neuritogenesis of cerebellar Purkinje neurons. J Mol Neurosci;46:336-42.

125. Swamy M, Sirajudeen KN, Chandran G. Nitric oxide (NO), citrulline-NO cycle enzymes, glutamine synthetase, and oxidative status in kainic acid-mediated excitotoxicity in rat brain. Drug Chem Toxicol. 2009;32:326–31.

126. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261–76.

127. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 1993;364:535–7.

128. Dykens JA. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration. J Neurochem. 1994;63:584–91.

129. Imam SZ, Karahalil B, Hogue BA, Souza-Pinto NC, Bohr VA. Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol Aging. 2006;27:1129–36.

130. Enriquez JA, Perez-Martos A, Fernandez-Silva P, Lopez-Perez MJ, Montoya J. RNA synthesis in isolated mitochondria from brain cortex, cerebellum and stem: evidence of different transcriptional rates. Int J Biochem. 1993;25:1951–6.

131. Desjardins P, Butterworth RF. Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke’s encephalopathy. Mol Neurobiol. 2005;31:17–25.

132. Avrova NF, Victorov IV, Tyurin VA, Zakharova IO, Sokolova TV, Andreeva NA, et al. Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochem Res. 1998;23:945–52.

133. Bulygina ER, Lyapina LY, Boldyrev AA. Activation of glutamate receptors inhibits Na/K-ATPase of cerebellum granule cells. Biochemistry (Mosc). 2002;67:1001–5.

134. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992;258:597–603.

135. Sommer B, Seeburg PH. Glutamate receptor channels: novel properties and new clones. Trends Pharmacol Sci. 1992;13:291–6.

136. Watkins JC, Krogsgaard-Larsen P, Honore T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci. 1990;11:25–33.

137. Okubo Y, Kakizawa S, Hirose K, Iino M. Cross talk between metabotropic and ionotropic glutamate receptor-mediated signaling in parallel fiber-induced inositol 1,4,5-trisphosphate production in cerebellar Purkinje cells. J Neurosci. 2004;24:9513–20.

138. Faingold C, Li Y, Evans MS. Decreased GABA and increased glutamate receptor-mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures. Brain Res. 2000;868:287–95.

139. Sanna E, Serra M, Cossu A, Colombo G, Follesa P, Cuccheddu T, et al. Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain. Alcohol Clin Exp Res. 1993;17:115–23.

140. Milne GL, Morrow JD, Picklo Sr MJ. Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal. Neurosci Lett. 2006;405:172–4.

141. Zaulyanov LL, Green PS, Simpkins JW. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell Mol Neurobiol. 1999;19:705–18.

142. Tan S, Wood M, Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem. 1998;71:95–105.

143. Heaton MB, Paiva M, Madorsky I, Siler-Marsiglio K, Shaw G. Effect of bax deletion on ethanol sensitivity in the neonatal rat cerebellum. J Neurobiol. 2006;66:95–101.

144. Siler-Marsiglio KI, Madorsky I, Pan Q, Paiva M, Neeley AW, Shaw G, et al. Effects of acute ethanol exposure on regulatory mechanisms of Bcl-2-associated apoptosis promoter, bad, in neonatal rat cerebellum: differential effects during vulnerable and resistant developmental periods. Alcohol Clin Exp Res. 2006;30:1031–8.

145. Slagsvold HH, Marvik OJ, Eidem G, Kristoffersen N, Paulsen RE. Detection of high molecular weight DNA fragments characteristic of early stage apoptosis in cerebellar granule cells exposed to glutamate. Exp Brain Res. 2000;135:173–8.

146. Ung ME, Ju X, Metzger DB, Simpkins JW. Ethanol withdrawal hastens the aging of cytochrome c oxidase. Neurobiol Aging 2012;33:618 e21-32.

147. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem. 2001;76:1–10.

148. Horstmann S, Kahle PJ, Borasio GD. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J Neurosci Res. 1998;52:483–90.

149. Kumar KA, Babu PP. Mitochondrial anomalies are associated with the induction of intrinsic cell death proteins-Bcl(2), Bax, cytochrome-c and p53 in mice brain during experimental fatal murine cerebral malaria. Neurosci Lett. 2002;329:319–23.

150. Chou AH, Lin AC, Hong KY, Hu SH, Chen YL, Chen JY, et al. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons. Neurochem Int. 2010;58:145–52.

151. Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN, et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 2002;419:367–74.

152. Cheung EC, Melanson-Drapeau L, Cregan SP, Vanderluit JL, Ferguson KL, McIntosh WC, et al. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J Neurosci. 2005;25:1324–34.

153. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128:669–81.

154. Melka MG, Laufer BI, McDonald P, Castellani CA, Rajakumar N, O’Reilly R, et al. The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum. Clin Epigenetics. 2014;6:1.

155. Al-Mahdawi S, Sandi C, Mouro Pinto R, Pook MA. Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus. PLoS One. 2013;8:e74956.

156. Priller J, Scherzer CR, Faber PW, MacDonald ME, Young AB. Frataxin gene of Friedreich’s ataxia is targeted to mitochondria. Ann Neurol. 1997;42:265–9.

157. Blossom SJ, Cooney CA, Melnyk SB, Rau JL, Swearingen CJ, Wessinger WD. Metabolic changes and DNA hypomethylation in cerebellum are associated with behavioral alterations in mice exposed to trichloroethylene postnatally. Toxicol Appl Pharmacol. 2013;269:263–9.

158. Wagner GR, Payne RM. Mitochondrial acetylation and diseases of aging. J Aging Res 2011;234875 doi:10.4061/2011/234875.

159. Yuzaki M. Cbln1 and its family proteins in synapse formation and maintenance. Curr Opin Neurobiol. 2011;21:215–20.

160. Guo W, Crossey EL, Zhang L, Zucca S, George OL, Valenzuela CF, et al. Alcohol exposure decreases CREB binding protein expression and histone acetylation in the developing cerebellum. PLoS One. 2011;6:e19351.

161. Yalcin A, Koulich E, Mohamed S, Liu L, D’Mello SR. Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB-binding protein and NF-kappaB. J Neurochem. 2003;84:397–408.

162. Pandey SC, Ugale R, Zhang H, Tang L, Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci. 2008;28:3729–37.

163. You C, Zhang H, Sakharkar AJ, Teppen T, Pandey SC. Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment. Int J Neuropsychopharmacol. 2013;17:313–22.

164. Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci U S A. 1999;96:4592–7.

165. Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, et al. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem. 1999;274:34940–7.

166. Zhang XD, Gillespie SK, Borrow JM, Hersey P. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. Mol Cancer Ther. 2004;3:425–35.

167. Djuranovic S, Nahvi A, Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science. 2012;336:237–40.

168. Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM, et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron. 2008;59:274–87.

169. Qi Y, Zhang M, Li H, Frank JA, Dai L, Liu H, et al. MicroRNA-29b regulates ethanol-induced neuronal apoptosis in the developing cerebellum through SP1/RAX/PKR cascade. J Biol Chem. 2014;289:10201–10.

170. Kryger R, Fan L, Wilce PA, Jaquet V. MALAT-1, a non protein-coding RNA is upregulated in the cerebellum, hippocampus and brain stem of human alcoholics. Alcohol. 2012;46:629–34.

171. Lewohl JM, Nunez YO, Dodd PR, Tiwari GR, Harris RA, Mayfield RD. Up-regulation of microRNAs in brain of human alcoholics. Alcohol Clin Exp Res. 2011;35:1928–37.

172. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A. 2007;104:11400–5.